Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
60,183.13 -2,936.23 (-4.65%) CMC Crypto 200
1,284.86 -54.20 (-4.05%)
Lotus Pharmaceutical Co., Ltd. (1795.TW)
Taiwan - Taiwan Delayed price. Currency in TWD
Add to watchlist
At close: 01:30PM CST
| Previous close | 329.00 |
| Open | 327.00 |
| Bid | 323.00 x N/A |
| Ask | 323.50 x N/A |
| Day's range | 323.50 - 330.00 |
| 52-week range | 205.00 - 349.50 |
| Volume | |
| Avg. volume | 6,913,053 |
| Market cap | 87.01B |
| Beta (5Y monthly) | 0.52 |
| PE ratio (TTM) | 20.61 |
| EPS (TTM) | 15.67 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | 3.46 (1.07%) |
| Ex-dividend date | 05 Jul 2023 |
| 1y target est | 433.33 |
- Business Wire
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY® in Multiple Markets Across Asia
BOSTON & TAIPEI, Taiwan, August 10, 2023--Corium, LLC ("Corium"), a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and Lotus Pharmaceutical (1795:TT; "Lotus"), a multinational pharmaceutical company, announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY® (donepezil transdermal system), an innovative Alzheimer’s dementia treatment, in ten markets across Asia.
© 2024 Yahoo. All rights reserved.